MIC and MBC describe different antimicrobial outcomes. The minimum inhibitory concentration, or MIC, identifies the concentration associated with stopping microbial growth, whereas the minimum bactericidal concentration, or MBC, reflects bactericidal activity. Considering both measurements can distinguish an agent that primarily suppresses growth from one that demonstrates killing, supporting more informative comparisons among antimicrobial treatments.
These approaches measure antimicrobial activity from different perspectives. Disk diffusion evaluates growth inhibition around an antimicrobial source, broth dilution examines responses across defined concentrations, and time-kill testing follows activity over time. Because each method emphasizes a different feature, selecting among them depends on whether the study needs an inhibition pattern, concentration-based susceptibility information, or a kinetic assessment of microbial response.
Susceptibility results depend on exposing microorganisms to defined antimicrobial concentrations and then measuring their response, such as growth inhibition. Comparing responses across concentrations helps identify how strongly an agent affects a microorganism and can reveal reduced susceptibility associated with resistant strains. Consistent concentration ranges and response measurements are therefore important when comparing isolates, agents, or experiments.
A typical workflow exposes microorganisms to selected, defined concentrations of an antimicrobial agent, measures the resulting response, and interprets the observation as an inhibition or killing outcome. The measurement method changes with the assay: disk diffusion records an inhibition pattern, broth dilution supports concentration-based endpoints, and time-kill testing tracks antimicrobial activity across time.
Time-kill testing is useful when the timing of antimicrobial activity matters, because it follows microbial responses over time rather than providing only a concentration-based endpoint. This approach can show how rapidly an agent affects microorganisms and whether activity changes during the observation period. Such information complements MIC or MBC results when evaluating antimicrobial performance and new therapies.
In immunology and infection research, antimicrobial testing connects laboratory measurements with clinically and biologically relevant questions. Results can help guide antibiotic selection, evaluate new therapies, investigate host-pathogen interactions, and monitor emerging resistant strains. These applications make susceptibility and activity measurements useful not only for treatment decisions, but also for studying how microorganisms respond during infection-related research.